Page last updated: 2024-11-06

zwittergent 3-14

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID84705
CHEBI ID10129
SCHEMBL ID61124
MeSH IDM0138954

Synonyms (40)

Synonym
14933-09-6
zwittergent 3-14
n-tetradecyl-n,n-dimethyl-3-ammonio-1-propanesulfonate
tetradecyldimethyl(3-sulfopropyl)ammonium hydroxide inner salt
T2653
3-[dimethyl(myristyl)ammonio]propane-1-sulfonate
3-[dimethyl(tetradecyl)ammonio]propane-1-sulfonate
myristyldimethyl(3-sulfopropyl)ammonium hydroxide inner salt
myristyl sulfobetaine
3-[dimethyl(tetradecyl)azaniumyl]propane-1-sulfonate
n-tetradecyl-n,n-dimethylammonium-1-propane-3-sulfonate
dimethyl(3-sulphonatopropyl)tetradecylammonium
einecs 239-003-9
u88xsy3j2l ,
unii-u88xsy3j2l
sb14
n-tetradecyl-n,n-dimethyl-3-amino-1-propane sulfonate
1-tetradecanaminium, n,n-dimethyl-n-(3-sulfopropyl)-, inner salt
3-(n,n-dimethylmyristylammonio)propanesulfonate
FT-0629568
SBB058241 ,
SCHEMBL61124
tetradecyldimethyl(3-sulfopropyl)ammonium hydroxide inner salt [for biochemical research]
CHEBI:10129
3-(dimethyl(tetradecyl)ammonio)propane-1-sulfonate
AKOS024375397
mfcd00036910
c19h41no3s
DTXSID2074538
AS-68391
J-008580
zwittergent 3-14 detergent
Q27108596
SB83672
3-(n,n-dimethylmyristylammonio)propane sulfonate
CS-0152223
sulfobetaine 14
tetradecyldimethyl(3-sulfopropyl)ammonium hydroxide
HY-W099581
SY052903
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organosulfonic acidAn organic derivative of sulfonic acid in which the sulfo group is linked directly to carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (18.75)18.7374
1990's3 (18.75)18.2507
2000's6 (37.50)29.6817
2010's4 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.62 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index29.80 (26.88)
Search Engine Supply Index2.30 (0.95)

This Compound (27.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]